nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—CYP1A2—chronic obstructive pulmonary disease	0.473	1	CbGaD
Erythromycin—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0766	0.21	CbGbCtD
Erythromycin—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0724	0.198	CbGbCtD
Erythromycin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0453	0.124	CbGbCtD
Erythromycin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0368	0.101	CbGbCtD
Erythromycin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0249	0.0681	CbGbCtD
Erythromycin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0237	0.065	CbGbCtD
Erythromycin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0211	0.0579	CbGbCtD
Erythromycin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0207	0.0567	CbGbCtD
Erythromycin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0196	0.0536	CbGbCtD
Erythromycin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0124	0.034	CbGbCtD
Erythromycin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0117	0.0321	CbGbCtD
Erythromycin—MLNR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00305	0.556	CbGeAlD
Erythromycin—Trauma—Formoterol—chronic obstructive pulmonary disease	0.00283	0.0279	CcSEcCtD
Erythromycin—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.0279	CcSEcCtD
Erythromycin—Trauma—Montelukast—chronic obstructive pulmonary disease	0.00277	0.0273	CcSEcCtD
Erythromycin—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.00262	0.0259	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00239	0.0236	CcSEcCtD
Erythromycin—Electrocardiogram QT prolonged—Formoterol—chronic obstructive pulmonary disease	0.0021	0.0207	CcSEcCtD
Erythromycin—Electrocardiogram QT prolonged—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.0207	CcSEcCtD
Erythromycin—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.0167	CcSEcCtD
Erythromycin—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.0165	CcSEcCtD
Erythromycin—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.0151	CcSEcCtD
Erythromycin—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.0121	CcSEcCtD
Erythromycin—Azithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.268	CrCbGaD
Erythromycin—Roxithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.268	CrCbGaD
Erythromycin—Telithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00115	0.261	CrCbGaD
Erythromycin—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0112	CcSEcCtD
Erythromycin—Trauma—Prednisone—chronic obstructive pulmonary disease	0.00111	0.011	CcSEcCtD
Erythromycin—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0105	CcSEcCtD
Erythromycin—Injury—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0105	CcSEcCtD
Erythromycin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.0103	CcSEcCtD
Erythromycin—Injury—Montelukast—chronic obstructive pulmonary disease	0.00104	0.0103	CcSEcCtD
Erythromycin—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0101	CcSEcCtD
Erythromycin—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00991	CcSEcCtD
Erythromycin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000977	0.00963	CcSEcCtD
Erythromycin—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000915	0.00902	CcSEcCtD
Erythromycin—Clarithromycin—CYP1A2—chronic obstructive pulmonary disease	0.000898	0.203	CrCbGaD
Erythromycin—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000882	0.0087	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000863	0.00851	CcSEcCtD
Erythromycin—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.000855	0.00843	CcSEcCtD
Erythromycin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000824	0.00812	CcSEcCtD
Erythromycin—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000813	0.00801	CcSEcCtD
Erythromycin—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000795	0.00784	CcSEcCtD
Erythromycin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000781	0.0077	CcSEcCtD
Erythromycin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000775	0.00764	CcSEcCtD
Erythromycin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000753	0.00742	CcSEcCtD
Erythromycin—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00075	0.00739	CcSEcCtD
Erythromycin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000749	0.00739	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000733	0.00722	CcSEcCtD
Erythromycin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00072	0.0071	CcSEcCtD
Erythromycin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000698	0.00688	CcSEcCtD
Erythromycin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00684	CcSEcCtD
Erythromycin—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00675	CcSEcCtD
Erythromycin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000671	0.00662	CcSEcCtD
Erythromycin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000663	0.00654	CcSEcCtD
Erythromycin—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00066	0.00651	CcSEcCtD
Erythromycin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000649	0.00639	CcSEcCtD
Erythromycin—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00636	CcSEcCtD
Erythromycin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00623	CcSEcCtD
Erythromycin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00618	CcSEcCtD
Erythromycin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000627	0.00618	CcSEcCtD
Erythromycin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000622	0.00613	CcSEcCtD
Erythromycin—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000605	0.00596	CcSEcCtD
Erythromycin—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000605	0.00596	CcSEcCtD
Erythromycin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00594	CcSEcCtD
Erythromycin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000603	0.00594	CcSEcCtD
Erythromycin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000598	0.00589	CcSEcCtD
Erythromycin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00588	CcSEcCtD
Erythromycin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00569	CcSEcCtD
Erythromycin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00569	CcSEcCtD
Erythromycin—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.00569	CcSEcCtD
Erythromycin—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000571	0.00563	CcSEcCtD
Erythromycin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000563	0.00555	CcSEcCtD
Erythromycin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00542	CcSEcCtD
Erythromycin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00537	CcSEcCtD
Erythromycin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00514	CcSEcCtD
Erythromycin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00514	CcSEcCtD
Erythromycin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.0051	CcSEcCtD
Erythromycin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00051	0.00503	CcSEcCtD
Erythromycin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000507	0.00499	CcSEcCtD
Erythromycin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000502	0.00495	CcSEcCtD
Erythromycin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00495	CcSEcCtD
Erythromycin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00495	CcSEcCtD
Erythromycin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00493	CcSEcCtD
Erythromycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00493	CcSEcCtD
Erythromycin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00493	CcSEcCtD
Erythromycin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.00489	CcSEcCtD
Erythromycin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000496	0.00489	CcSEcCtD
Erythromycin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00485	CcSEcCtD
Erythromycin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.00481	CcSEcCtD
Erythromycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00474	CcSEcCtD
Erythromycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00474	CcSEcCtD
Erythromycin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00467	CcSEcCtD
Erythromycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00467	CcSEcCtD
Erythromycin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.00465	CcSEcCtD
Erythromycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000471	0.00465	CcSEcCtD
Erythromycin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00462	CcSEcCtD
Erythromycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00459	CcSEcCtD
Erythromycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00448	CcSEcCtD
Erythromycin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00443	CcSEcCtD
Erythromycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00441	CcSEcCtD
Erythromycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00433	CcSEcCtD
Erythromycin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00427	CcSEcCtD
Erythromycin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00426	CcSEcCtD
Erythromycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00416	CcSEcCtD
Erythromycin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00413	CcSEcCtD
Erythromycin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000418	0.00412	CcSEcCtD
Erythromycin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00406	CcSEcCtD
Erythromycin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00406	CcSEcCtD
Erythromycin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00397	CcSEcCtD
Erythromycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00396	CcSEcCtD
Erythromycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00393	CcSEcCtD
Erythromycin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00391	CcSEcCtD
Erythromycin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00391	CcSEcCtD
Erythromycin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00389	CcSEcCtD
Erythromycin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00389	CcSEcCtD
Erythromycin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00388	CcSEcCtD
Erythromycin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00388	CcSEcCtD
Erythromycin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00383	CcSEcCtD
Erythromycin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000385	0.0038	CcSEcCtD
Erythromycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00377	CcSEcCtD
Erythromycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00377	CcSEcCtD
Erythromycin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00375	CcSEcCtD
Erythromycin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00375	CcSEcCtD
Erythromycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00374	CcSEcCtD
Erythromycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00371	CcSEcCtD
Erythromycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.0037	CcSEcCtD
Erythromycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00369	CcSEcCtD
Erythromycin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00369	CcSEcCtD
Erythromycin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00367	CcSEcCtD
Erythromycin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00366	CcSEcCtD
Erythromycin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000368	0.00362	CcSEcCtD
Erythromycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00356	CcSEcCtD
Erythromycin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00354	CcSEcCtD
Erythromycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00349	CcSEcCtD
Erythromycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00349	CcSEcCtD
Erythromycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000354	0.00349	CcSEcCtD
Erythromycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00342	CcSEcCtD
Erythromycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00336	CcSEcCtD
Erythromycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00336	CcSEcCtD
Erythromycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.0033	CcSEcCtD
Erythromycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00329	CcSEcCtD
Erythromycin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00325	CcSEcCtD
Erythromycin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00325	CcSEcCtD
Erythromycin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.00323	CcSEcCtD
Erythromycin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00322	CcSEcCtD
Erythromycin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00318	CcSEcCtD
Erythromycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00317	CcSEcCtD
Erythromycin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.00315	CcSEcCtD
Erythromycin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00314	CcSEcCtD
Erythromycin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00314	CcSEcCtD
Erythromycin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00307	CcSEcCtD
Erythromycin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00306	CcSEcCtD
Erythromycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00302	CcSEcCtD
Erythromycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00302	CcSEcCtD
Erythromycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00299	CcSEcCtD
Erythromycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00299	CcSEcCtD
Erythromycin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00296	CcSEcCtD
Erythromycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00295	CcSEcCtD
Erythromycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00293	CcSEcCtD
Erythromycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00285	CcSEcCtD
Erythromycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00283	CcSEcCtD
Erythromycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00282	CcSEcCtD
Erythromycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00282	CcSEcCtD
Erythromycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00282	CcSEcCtD
Erythromycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00276	CcSEcCtD
Erythromycin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00273	CcSEcCtD
Erythromycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00266	CcSEcCtD
Erythromycin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.00265	CcSEcCtD
Erythromycin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00261	CcSEcCtD
Erythromycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00257	CcSEcCtD
Erythromycin—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000255	0.0465	CbGeAlD
Erythromycin—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000247	0.045	CbGeAlD
Erythromycin—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000238	0.0434	CbGeAlD
Erythromycin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00235	CcSEcCtD
Erythromycin—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000237	0.0432	CbGeAlD
Erythromycin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00229	CcSEcCtD
Erythromycin—ABCC1—trachea—chronic obstructive pulmonary disease	0.000229	0.0418	CbGeAlD
Erythromycin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.0022	CcSEcCtD
Erythromycin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00212	CcSEcCtD
Erythromycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00205	CcSEcCtD
Erythromycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00204	CcSEcCtD
Erythromycin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00198	CcSEcCtD
Erythromycin—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000201	0.0366	CbGeAlD
Erythromycin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00192	CcSEcCtD
Erythromycin—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000195	0.0355	CbGeAlD
Erythromycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00189	CcSEcCtD
Erythromycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00187	CcSEcCtD
Erythromycin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00178	CcSEcCtD
Erythromycin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.0017	CcSEcCtD
Erythromycin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00162	CcSEcCtD
Erythromycin—ABCC1—lung—chronic obstructive pulmonary disease	0.000165	0.03	CbGeAlD
Erythromycin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00162	CcSEcCtD
Erythromycin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00154	CcSEcCtD
Erythromycin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Erythromycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Erythromycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00148	CcSEcCtD
Erythromycin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00148	CcSEcCtD
Erythromycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00138	CcSEcCtD
Erythromycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00132	CcSEcCtD
Erythromycin—CYP1A2—lung—chronic obstructive pulmonary disease	0.000131	0.0239	CbGeAlD
Erythromycin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00128	CcSEcCtD
Erythromycin—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000126	0.0231	CbGeAlD
Erythromycin—CYP3A5—lung—chronic obstructive pulmonary disease	0.000126	0.0231	CbGeAlD
Erythromycin—CYP2B6—lung—chronic obstructive pulmonary disease	0.000126	0.0229	CbGeAlD
Erythromycin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00123	CcSEcCtD
Erythromycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00119	CcSEcCtD
Erythromycin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00118	CcSEcCtD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000113	0.00225	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00225	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00225	CbGpPWpGaD
Erythromycin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00225	CbGpPWpGaD
Erythromycin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00111	CcSEcCtD
Erythromycin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00222	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.0022	CbGpPWpGaD
Erythromycin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00011	0.00219	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00218	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000108	0.00215	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.0021	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000104	0.00207	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00206	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000103	0.00204	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.98e-05	0.00198	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.95e-05	0.00198	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.00193	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	9.72e-05	0.00193	CbGpPWpGaD
Erythromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.6e-05	0.00191	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.56e-05	0.0019	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.43e-05	0.00187	CbGpPWpGaD
Erythromycin—ABCB1—trachea—chronic obstructive pulmonary disease	9.35e-05	0.017	CbGeAlD
Erythromycin—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	9.29e-05	0.00184	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.28e-05	0.00184	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.23e-05	0.00183	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.22e-05	0.00183	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.21e-05	0.00183	CbGpPWpGaD
Erythromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.16e-05	0.00182	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.00181	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.06e-05	0.0018	CbGpPWpGaD
Erythromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.04e-05	0.00179	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.01e-05	0.00179	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.00177	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.89e-05	0.00176	CbGpPWpGaD
Erythromycin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.75e-05	0.00174	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.6e-05	0.00171	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	8.36e-05	0.00166	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.29e-05	0.00165	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.23e-05	0.00163	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.89e-05	0.00157	CbGpPWpGaD
Erythromycin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.74e-05	0.00154	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.69e-05	0.00153	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.00151	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.56e-05	0.0015	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.53e-05	0.00149	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.52e-05	0.00149	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.48e-05	0.00148	CbGpPWpGaD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.43e-05	0.00147	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.42e-05	0.00147	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	7.29e-05	0.00145	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.24e-05	0.00144	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.2e-05	0.00143	CbGpPWpGaD
Erythromycin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.11e-05	0.00141	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.0014	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.07e-05	0.0014	CbGpPWpGaD
Erythromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.98e-05	0.00139	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.97e-05	0.00138	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.91e-05	0.00137	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.81e-05	0.00135	CbGpPWpGaD
Erythromycin—ABCB1—lung—chronic obstructive pulmonary disease	6.72e-05	0.0122	CbGeAlD
Erythromycin—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.00133	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.69e-05	0.00133	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.62e-05	0.00131	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.00131	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.0013	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.53e-05	0.0013	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.46e-05	0.00128	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.46e-05	0.00128	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.39e-05	0.00127	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.27e-05	0.00124	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.15e-05	0.00122	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.1e-05	0.00121	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	5.99e-05	0.00119	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.96e-05	0.00118	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.73e-05	0.00114	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.64e-05	0.00112	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.56e-05	0.0011	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.54e-05	0.0011	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.5e-05	0.00109	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.49e-05	0.00109	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.39e-05	0.00107	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	5.39e-05	0.00107	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.31e-05	0.00105	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.31e-05	0.00105	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.27e-05	0.00105	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.25e-05	0.00104	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.1e-05	0.00101	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.04e-05	0.001	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.01e-05	0.000995	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.01e-05	0.000994	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.98e-05	0.000989	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.98e-05	0.000989	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.87e-05	0.000967	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.83e-05	0.000959	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.78e-05	0.000948	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.78e-05	0.000948	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.77e-05	0.000947	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.7e-05	0.000932	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.59e-05	0.000912	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.55e-05	0.000903	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.55e-05	0.000903	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.53e-05	0.000899	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.47e-05	0.000887	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.45e-05	0.000883	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.43e-05	0.00088	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.37e-05	0.000867	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.31e-05	0.000856	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.29e-05	0.000852	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.23e-05	0.000839	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.000832	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.16e-05	0.000826	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.00082	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.11e-05	0.000815	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.02e-05	0.000798	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.99e-05	0.000792	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.98e-05	0.000789	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.96e-05	0.000786	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.95e-05	0.000783	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.000772	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.84e-05	0.000762	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.7e-05	0.000734	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.61e-05	0.000717	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.000709	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.5e-05	0.000694	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.49e-05	0.000693	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.47e-05	0.00069	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.45e-05	0.000684	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.4e-05	0.000674	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.31e-05	0.000658	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-05	0.000649	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.25e-05	0.000645	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-05	0.000642	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000641	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000638	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.17e-05	0.00063	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.17e-05	0.000629	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.16e-05	0.000627	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.000604	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.01e-05	0.000598	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.000596	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	2.95e-05	0.000586	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-05	0.000585	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.94e-05	0.000584	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.91e-05	0.000577	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.87e-05	0.000569	CbGpPWpGaD
Erythromycin—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.75e-05	0.000545	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.73e-05	0.000542	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.72e-05	0.000539	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.71e-05	0.000538	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.65e-05	0.000527	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.63e-05	0.000523	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.58e-05	0.000512	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.57e-05	0.000509	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.56e-05	0.000509	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.54e-05	0.000504	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000496	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.45e-05	0.000486	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000485	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.38e-05	0.000473	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000459	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.27e-05	0.00045	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000449	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.24e-05	0.000444	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000423	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.13e-05	0.000423	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.1e-05	0.000417	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.000413	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.06e-05	0.000408	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.05e-05	0.000406	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.04e-05	0.000406	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.04e-05	0.000405	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.01e-05	0.000399	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000392	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.95e-05	0.000388	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.92e-05	0.00038	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.9e-05	0.000377	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000377	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000372	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.87e-05	0.000372	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.86e-05	0.000368	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.000364	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.82e-05	0.000362	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000353	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000353	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000348	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.72e-05	0.000341	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.00034	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.000332	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000324	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.62e-05	0.000322	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.61e-05	0.000319	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000313	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000313	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000308	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000306	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000301	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000291	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.000287	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000278	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000275	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000274	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000266	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000261	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000258	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000255	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000255	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-05	0.000252	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000251	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000243	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.00024	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000235	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000231	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000227	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000222	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000222	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000219	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000209	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000204	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.0002	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.0002	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.7e-06	0.000193	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.57e-06	0.00019	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	9.12e-06	0.000181	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	8.94e-06	0.000178	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.92e-06	0.000177	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.62e-06	0.000171	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.52e-06	0.000169	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.45e-06	0.000168	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	0.000155	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.78e-06	0.000154	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.75e-06	0.000154	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.64e-06	0.000152	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.61e-06	0.000151	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-06	0.000148	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.28e-06	0.000145	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.17e-06	0.000142	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.12e-06	0.000141	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	6.87e-06	0.000136	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.75e-06	0.000134	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.98e-06	0.000119	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.9e-06	0.000117	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.75e-06	0.000114	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.5e-06	0.000109	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.49e-06	0.000109	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.21e-06	0.000103	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-06	9.1e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-06	8.71e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.54e-06	7.03e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.39e-06	6.72e-05	CbGpPWpGaD
